Drug Shortage Report for PMS-IRBESARTAN-HCTZ
| Report ID | 188954 |
| Drug Identification Number | 02328526 |
| Brand name | PMS-IRBESARTAN-HCTZ |
| Common or Proper name | IRBESARTAN-HCTZ |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-14 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-04-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-04-06 | French | Compare |
| v1 | 2023-04-06 | English | Compare |
Showing 1 to 2 of 2